Schedule 13G ownership disclosure
Salarius Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 79400X107
Event date: 2022-04-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-22-000846
- Form type
- SC 13G
- Filer
- Lind Global Fund II LP
- CIK
- CIK 1871665
- Filed
- Apr 29, 2022
- Reporting period
- Apr 26, 2022
- Description
- Schedule 13G beneficial ownership